Adenosine inhibits the release of interleukin-1β in activated human peripheral mononuclear cells

Cytokine

Volumn 31, Issue 4, 2005, Pages 258-263

  Sipka, Sandor ^a   Kovács, Ildikó ^a   Szántó, Sándor ^a   Szegedi, Gyula ^a   Brugós, László ^b   Bruckner, Geza ^c   Jozsef Szentmiklosi A ^b  

^a UNIVERSITY OF DEBRECEN   (Hungary)

^b UNIVERSITY OF DEBRECEN   (Hungary)

^c UNIVERSITY OF KENTUCKY   (United States)

Author keywords

Adenosine; Adenosine receptors; Human mononuclear cells; Interleukin 1

Indexed keywords

1,4 DIHYDRO 2 METHYL 6 PHENYL 4 (2 PHENYLETHYNYL) 3,5 PYRIDINEDICARBOXYLIC ACID 5 BENZYL 3 ETHYL ESTER; 2 [4 (2 CARBOXYETHYL)PHENETHYLAMINO]ADENOSINE 5' (N ETHYLCARBOXAMIDE); 4 [2 [7 AMINO 2 (2 FURYL) 1,2,4 TRIAZOLO[2,3 A][1,3,5]TRIAZIN 5 YLAMINO]ETHYL]PHENOL; 6 N (3 IODOBENZYL) 5 (N METHYLCARBOXAMIDOADENOSINE); 6 N CYCLOPENTYLADENOSINE; 8 CYCLOPENTYL 1,3 DIPROPYLXANTHINE; ADENOSINE; ADENOSINE 5' (N ETHYLCARBOXAMIDE); ADENOSINE A1 RECEPTOR; ADENOSINE A2A RECEPTOR; ADENOSINE A2B RECEPTOR; ADENOSINE A3 RECEPTOR; ADENOSINE RECEPTOR BLOCKING AGENT; ADENOSINE RECEPTOR STIMULATING AGENT; CALCIMYCIN; INTERLEUKIN 1BETA; PHORBOL ESTER; PROTEIN KINASE C; UNCLASSIFIED DRUG;

ARTICLE; CELL ACTIVATION; CELL VIABILITY; CONTROLLED STUDY; CYTOKINE RELEASE; DRUG EFFECT; DRUG MECHANISM; DRUG POTENCY; HUMAN; HUMAN CELL; LYMPHOCYTE; MONOCYTE; MONONUCLEAR CELL; PRIORITY JOURNAL; STATISTICAL ANALYSIS;

ADENOSINE; CALCIMYCIN; HUMANS; INTERLEUKIN-1; MONOCYTES; PHENETHYLAMINES; RECEPTORS, PURINERGIC P1; TETRADECANOYLPHORBOL ACETATE;

EID: 23244457391     PISSN: 10434666     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cyto.2005.05.002     Document Type: Article

References (44)

1. C.A. Dinarello Interleukin-1 and interleukin-1 antagonism Blood 77 1991 1627 1652
2. F. Colotta, P. Ghezzi, and A. Mantovani Interleukin 1 A.R. Mire-Sluis R. Thorpe Cytokines 1998 Academic Press San Diego, London, Boston, New York, Sydney, Tokyo, Toronto 1 18
3. D.G. Perregaux, R.E. Laliberte, and C.A. Gabel Human monocyte interleukin-1β posttranslational processing. Evidence of a volume-regulated response J Biol Chem 271 1996 29830 29838
4. M.G. Bouma, R.K. Stad, F.A. van den Wildenberg, and W.A. Buurman Differential regulatory effects of adenosine on cytokine release by activated monocytes J Immunol 153 1994 4159 4168
5. Z. Zidek Adenosine-cyclic AMP pathways and cytokine expression Eur Cytokine Netw 10 1999 319 328
6. 2A adenosine receptor: a novel therapeutic target in renal disease Am J Physiol (Renal Physiol) 282 2002 F10 F18
7. 2A receptor agonists promote more rapid wound healing than recombinant human platelet-derived growth factor (Becaplermin Gel) Inflammation 26 2002 19 24
8. 2A adenosine receptor in vivo J Immunol 173 2004 21 24
9. 3 receptor decreases interleukin-12 and interferon-γ production and prevents lethality in endotoxemic mice Eur J Pharmacol 358 1998 261 268
10. 2A receptor-dependent and independent mechanisms FASEB J 14 2000 2065 2074
11. 2A receptors inhibits IL-12 production by human monocytes J Immunol 164 2000 436 442
12. O. Le Moine, P. Stordeur, L. Schanane, A. Marchant, D. De Groote, and M. Goldman Adenosine enhances IL-10 secretion by human monocytes J Immunol 156 1996 4408 4414
13. F.G. Sajjadi, K. Takabayashi, A.C. Foster, R.C. Domingo, and G.S. Firestein Inhibition of TNF-α expression by adenosine. Role of A3 adenosine receptors J Immunol 156 1996 3435 3442
14. M.E. Olah, and G.L. Stiles Adenosine receptor subtypes: characterization and therapeutic regulation Annu Rev Pharmacol Toxicol 35 1995 581 606
15. B.R. Cobb, and J.P. Clancy Molecular and cell biology of adenosine receptors Curr Top Membr 54 2003 51 181
16. K. McCallion, D.W. Harkin, and K.R. Gardiner Role of adenosine in immunomodulation: review of the literature Crit Care Med 32 2004 273 277
17. 2 receptors to inhibit IL-12 induced tyrosine phosphorylation of STAT5 T lymphocytes: role of cyclic adenosine 3′,5′monophosphate and phosphatases J Immunol 173 2004 932 944
18. K. Yamato, Z. el Hajjaouzi, and H.P. Koeffler Regulation of levels of IL-1 mRNA in human fibroblasts J Cell Physiol 139 1989 610 616
19. 2+ in regulation of IL-1(beta) secretion by P2X7 nucleotide receptor in monocytes, macrophages, and HEK-293 cells Am J Physiol (Cell Physiol) 285 2003 C286 C299
20. 2A adenosine receptor phosphorylation by protein kinase C activation: evidence for regulation by multiple protein kinase C isoforms Biochemistry 38 1999 14833 14842
21. D. Lorton Beta-amyloid induced IL-1 beta release from an activated human monocyte cell line is calcium- and G protein dependent Mech Ageing Dev 94 1997 199 211
22. 2 control lysosome mediated IL-1β secretion: implications for inflammatory processes Proc Natl Acad Sci U S A 101 2004 9745 9750
23. R.J. Bing, R. Dudek, J. Kahler, K.S. Narayan, and M. Ingram Cytokine production from freshly harvested human mononuclear cells attached to plastic beads Tissue Cell 24 1992 203 209
24. 1 receptor promotion of multinucleated giant cell formation by human monocytes Arthritis Rheum 40 1997 1308 1315
25. 2A- adenosine receptors in human peripheral blood cells Br J Pharmacol 129 2000 2 11
26. 1 receptors Int J Biochem 8 1994 959 969
27. 3 adenosine receptors in lymphoid organs Biochem Pharmacol 65 2003 2082 2090
28. 2A receptors in human monocytic THP-1 cells J Immunol 167 2001 4026 4032
29. Z.H. Németh, S.J. Leibovich, E.A. Deitch, B. Sperlágh, L. Virág, and E.S. Vizi Adenosine stimulates CREB activation in macrophages via a p38 MAPK-mediated mechanism Biochem Biophys Res Commun 312 2003 883 888
30. S. Majumdar, and B.B. Aggarwal Adenosine suppresses activation of nuclear factor-κB selectively induced by tumor necrosis factor in different cell types Oncogene 22 2003 1206 1218
31. 2A adenosine receptors by proinflammatory cytokines in rat PC12 cells Biochem Pharmacol 64 2002 625 631
32. 2B receptors Biochem Pharmacol 55 1998 627 633
33. S. Sipka, S. Szántó, K. Szucs, I. Kovács, E. Kiss, and P. Antal-Szalmás Decreased arachidonic acid release in peripheral blood monocytes of patients with systemic lupus erythematosus J Rheumatol 28 2001 2012 2017
34. 2A adenosine receptors in inflammation Drug Dev Res 45 1998 103 112
35. 2a adenosine receptors to engineer inflammation in vivo Int J Biochem Cell Biol 35 2003 410 414
36. S. Sipka, T. Seres, Z. Dinya, Z. Szekanecz, A.J. Szentmiklósi, and E. Bodolay Tumour necrosis factor-α and adenosine in endotoxin shock related cardiovascular symptoms Mediators Inflamm 4 1995 454 455
37. C. Martin, M. Leone, X. Viviand, M.L. Ayem, and R. Guieu High adenosine plasma concentration as a prognostic index for outcome in patients with septic shock Crit Care Med 28 2000 3198 3202
38. B.N. Cronstein Adenosine, an endogenous anti-inflammatory agent J Appl Physiol 76 1994 5 13
39. M.T. Matuszek, and I.T. Gagato The antipyretic activity of adenosine agonists Gen Pharmacol 29 1997 371 374
40. B. Conti, I. Tabarean, C. Andrei, and T. Bartfai Cytokines and fever Front Biosci 9 2004 1433 1449
41. G. Haskó, and B.N. Cronstein Adenosine: an endogenous regulator of innate immunity Trends Immunol 25 2004 33 39
42. B.N. Cronstein, D. Naime, and E. Ostad The antiinflammatory mechanisms of methotrexate: increased adenosine release at inflamed sites diminishes leukocyte accumulation in an in vivo model of inflammation J Clin Invest 92 1993 2675 2682
43. M. Seitz, M. Zwicker, and P. Loetscher Effects of methotrexate on differentiation of monocytes and production of cytokine inhibitors by monocytes Arthritis Rheum 41 1998 2032 2038
44. A. Boyum Isolation of mononuclear cells and granulocytes from human blood Scand J Clin Lab Invest 97 Suppl. 1968 77 108